Webinar: Economic Modelling Challenges in Rare Diseases

When seeking approval for rare disease products, demonstrating value for therapies can be a challenge. The limited amount of data available affects the feasibility of developing models that meet good practice recommendations for health technology assessment submissions. Join us for this webinar where our health economics consulting experts will discuss different approaches for developing a rigorous economic model structure for rare disease research that can help you gain orphan drug reimbursement.

View this webinar where you’ll learn:

• Health Technology Assessment:
  • How do HTA bodies define rare or ultra-orphan diseases?
  • How do HTA bodies appraise rare disease drugs?
• What are the key challenges to developing cost-effectiveness models?
• How do we overcome these HTA economic modelling challenges?